About Lindsay Rosenwald
Landmark Individuals: Dr. Lindsay Rosenwald
Many individuals in the medical and financial industries may already be familiar with the name Lindsay Rosenwald, or if not, then at least with the companies he founded. The exact extent of his impact on the medical industry (primarily in the bioresearch, biotechnology, and development sectors) still remain unknown even to those familiar with his basic work. Lindsay Rosenwald is not merely a successful investor, however. He is a successful entrepreneur that has revolutionized the way we look at medical investment, he has helped to create immense positive changes in the medical industry, and he has selflessly worked to create the Rosenwald Foundation – an NPO that helps fund the scientific community and medical education institutions.
Knowing the best place to start when enumerating the success of Dr. Lindsay Rosenwald can be difficult. We can go back as far as 1973, when he graduated Betta Gamma Sigma (a business school honor society) from Pennsylvania State University. His degree was in finance, but he moved on to the Temple University School of Medicine where he received his M.D.. While he did work briefly in Abington Medical Hospital, he then proceeded to start his own private practice, and then made a shift that would allow him to make the impact he has today.
The Biotechnology Group is divided into several different companies, each with a unique aim and purpose, but all constructed in a way meant to drive success for its portfolio companies. The real foundation of the company is a certified broker-dealer which generates the needed funds to successfully execute the research and development stages that are so important to the success of each company. With the resources ready, the BioScience group then researches companies who could use the funding well. They look for companies doing groundbreaking research that can revolutionize the industry (as well as see financial success).
This plan was created by founder Lindsay Rosenwald in order to see the greatest success possible. The fact that he, unlike so many other investors and financial researchers, has practical experience in both the medical and financial industries, allows him to anticipate the difficulties that these companies were likely to face and prepare them appropriately. As a result, these companies have seen immense success. The drug Aresneic Trioxide currently holds the record for shortest approval time by the FDA. Treatment for major diseases like leukemia, prostate cancer, and solid tumors, have all been advanced by the portfolio companies that Lindsay Rosenwald helped to establish.
Over forty companies have been assisted in funding and development since 1991. The last few years have actually shown an increase in the number of investments from the Bio Tech Group. In addition to increasing the number, they are expanding their horizons by working with privately owned companies in addition to publicly owned companies. Lindsay Rosenwald remains at the foundation of it all.
Commercial success does not seem to be the only goal for Lindsay Rosenwald, however. As the father of the Rosenwald Foundation, Lindsay Rosenwald has helped get hundreds of millions of dollars to the scientific community, the research and development community, and educational institutions. His impact on the industry looks likely to continue for many years to come, for this and many other reasons.
In just two decades, Lindsay Rosenwald has successfully helped revolutionize the medical industry. Not only have improved treatments been found, but the way that medical development is viewed in the financial sector has been adapted to mimic his success. Of the landmark individuals in today’s world, the financial and medical sectors must both look up to the accomplishments of Dr. Lindsay Rosenwald.
